Skip to content

Advertisement

BMC Neurology

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Rationale, design, and methods of a non-interventional study to establish safety, effectiveness, quality of life, cognition, health-related and work capacity data on Alemtuzumab in multiple sclerosis patients in Germany (TREAT-MS)

BMC NeurologyBMC series – open, inclusive and trusted201616:109

https://doi.org/10.1186/s12883-016-0629-9

Received: 9 February 2016

Accepted: 14 June 2016

Published: 19 July 2016

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
9 Feb 2016 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
14 Jun 2016 Editorially accepted
19 Jul 2016 Article published 10.1186/s12883-016-0629-9

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Center of Clinical Neuroscience, Carl Gustav Carus University Hospital, Dresden, Germany
(2)
Medical Affairs, Genzyme GmbH, Neu-Isenburg, Germany
(3)
Clinical Study Unit, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany

Advertisement